HSTM on Nasdaq
HEALTHSTREAM INC
HealthStream’s focus is and has always been on improving the quality of healthcare through the development and support of the dedicated individuals who deliver care.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Health Catalyst, Inc., Eventbrite or PubMatic, Inc., or pick any stock.
- TickerHSTM on Nasdaq2
- IndustryServices-Computer Programming, Data Processing, Etc.2
- HeadquartersNashville, United States2
- Incorporated inTN3
- Business address500 11Th Avenue North, Suite 850, Nashville, Tn3
- Filer categoryAccelerated filer3
- Legal formCorporation2
- LEI529900OJ88H8635JNH642
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered address209 10th Avenue, South, Suite 450, 37203 Nashville, United States2
- Registered withBusiness Services (Department of State), 0002330532
See how the biggest companies compare on our leaderboards
HealthStream’s focus is and has always been on improving the quality of healthcare through the development and support of the dedicated individuals who deliver care. Like healthcare itself, our mission remains constant, but how we accomplish that mission continues to evolve and improve over time. Originally, we pioneered the use of online learning to hospitals, which began with courses specifically tailored to educate healthcare professionals and meet hospitals' required regulatory needs, and we remain a leading innovator in those areas today. Since our inception, the scope of HealthStream’s Software-as-a-Service (SaaS) solutions has expanded well beyond our governance, risk, and compliance (GRC) offerings to include a diverse ecosystem of applications that optimize and support the healthcare workforce and the students preparing to enter that workforce. Today, we are characterized by our…4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Subscription Services brought in 97% of the revenue HEALTHSTREAM INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Subscription Services | $267.9M | $280.3M | $293.6M |
| Professional Services | $11.1M | $11.3M | $10.4M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development17¢$51.0M
- Other costs76¢$229.9M
- Income tax2¢$4.9M
- Profit6¢$18.3M
Out of $304.1M in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending6¢$3.7M
- Dividends paid6¢$3.7M
- Share buybacks47¢$30.0M
- Kept or used elsewhere41¢$25.9M
Out of $63.3M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues, net | $304.1M | $291.6M | $279.1M |
| Cost of revenues (excluding depreciation and amortization) | $107.2M | $97.9M | $95.0M |
| Product development | $51.0M | $48.9M | $45.5M |
| Sales and marketing | $49.4M | $47.2M | $45.7M |
| General and administrative expenses | $32.8M | $35.1M | $35.7M |
| Depreciation and amortization | $43.5M | $41.2M | $41.1M |
| Total operating costs and expenses | $283.8M | $270.4M | $263.0M |
| Operating income | $20.2M | $21.3M | $16.0M |
| Interest income | $3.3M | $3.8M | $2.4M |
| Other (expense) income, net | -$358.0K | -$318.0K | $136.0K |
| Income before income tax provision | $23.2M | $24.8M | $18.5M |
| Income tax provision | $4.9M | $4.8M | $3.3M |
| Net income | $18.3M | $20.0M | $15.2M |
| Basic (in dollars per share) | $0.61 | $0.66 | $0.50 |
| Diluted (in dollars per share) | $0.61 | $0.66 | $0.50 |
| Basic (in shares) | 30.0M shares | 30.4M shares | 30.6M shares |
| Diluted (in shares) | 30.1M shares | 30.5M shares | 30.7M shares |
| Dividends declared per share (in dollars per share) | $0.12 | $0.11 | $0.10 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $36.2M | $59.5M | ||
| Marketable securities | $20.8M | $37.7M | ||
| Accounts receivable, net | $32.2M | $30.2M | ||
| Accounts receivable - unbilled | $6.8M | $5.1M | ||
| Prepaid royalties, net of amortization | $7.6M | $9.5M | ||
| Prepaid software maintenance and subscriptions | $9.3M | $8.6M | ||
| Other prepaid expenses and other current assets | $6.7M | $2.5M | ||
| Total current assets | $119.7M | $153.1M | ||
| Property and equipment, net | $10.7M | $10.7M | ||
| Capitalized software development, net | $45.6M | $43.4M | ||
| Operating lease right of use assets, net | $15.3M | $17.5M | ||
| Goodwill | $217.5M | $191.2M | $191.4M | |
| Intangibles, net | $64.9M | $55.5M | ||
| Other assets | $46.8M | $39.3M | ||
| Total assets | $520.4M | $510.8M | ||
| Accounts Payable, Current | $7.8M | $6.6M | ||
| Accrued royalties | $5.6M | $5.2M | ||
| Accrued liabilities | $11.2M | $10.1M | ||
| Accrued compensation | $11.2M | $9.5M | ||
| Deferred revenue | $88.4M | $84.2M | ||
| Total current liabilities | $124.1M | $115.7M | ||
| Deferred tax liabilities | $18.2M | $14.6M | ||
| Deferred revenue, noncurrent | $1.3M | $1.7M | ||
| Operating lease liability, noncurrent | $14.7M | $17.4M | ||
| Other long-term liabilities | $7.9M | $2.1M | ||
| Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding | $0 | $0 | ||
| Common stock, no par value, 75,000 shares authorized; 29,579 and 30,432 shares issued and outstanding at December 31, 2025 and 2024, respectively | $231.8M | $252.4M | ||
| Retained earnings | $123.6M | $109.0M | ||
| Accumulated other comprehensive loss | -$1.4M | -$2.0M | ||
| Total shareholders equity | $354.0M | $359.4M | $340.8M | $334.1M |
| Total liabilities and shareholders equity | $520.4M | $510.8M | ||
| Preferred stock, par value (in dollars per share) | $0 | $0 | ||
| Preferred stock, authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, shares authorized (in shares) | 75.0M shares | 75.0M shares | ||
| Common stock, shares issued (in shares) | 29.6M shares | 30.4M shares | ||
| Common stock, shares outstanding (in shares) | 29.6M shares | 30.4M shares | ||
| Common stock, par value (in dollars per share) | $0 | $0 |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $36.2M | $59.5M | ||
| Marketable securities | $20.8M | $37.7M | ||
| Accounts receivable, net | $32.2M | $30.2M | ||
| Accounts receivable - unbilled | $6.8M | $5.1M | ||
| Prepaid royalties, net of amortization | $7.6M | $9.5M | ||
| Prepaid software maintenance and subscriptions | $9.3M | $8.6M | ||
| Other prepaid expenses and other current assets | $6.7M | $2.5M | ||
| Total current assets | $119.7M | $153.1M | ||
| Property and equipment, net | $10.7M | $10.7M | ||
| Capitalized software development, net | $45.6M | $43.4M | ||
| Operating lease right of use assets, net | $15.3M | $17.5M | ||
| Goodwill | $217.5M | $191.2M | $191.4M | |
| Intangibles, net | $64.9M | $55.5M | ||
| Other assets | $46.8M | $39.3M | ||
| Total assets | $520.4M | $510.8M | ||
| Accounts Payable, Current | $7.8M | $6.6M | ||
| Accrued royalties | $5.6M | $5.2M | ||
| Accrued liabilities | $11.2M | $10.1M | ||
| Accrued compensation | $11.2M | $9.5M | ||
| Deferred revenue | $88.4M | $84.2M | ||
| Total current liabilities | $124.1M | $115.7M | ||
| Deferred tax liabilities | $18.2M | $14.6M | ||
| Deferred revenue, noncurrent | $1.3M | $1.7M | ||
| Operating lease liability, noncurrent | $14.7M | $17.4M | ||
| Other long-term liabilities | $7.9M | $2.1M | ||
| Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding | $0 | $0 | ||
| Common stock, no par value, 75,000 shares authorized; 29,579 and 30,432 shares issued and outstanding at December 31, 2025 and 2024, respectively | $231.8M | $252.4M | ||
| Retained earnings | $123.6M | $109.0M | ||
| Accumulated other comprehensive loss | -$1.4M | -$2.0M | ||
| Total shareholders equity | $354.0M | $359.4M | $340.8M | $334.1M |
| Total liabilities and shareholders equity | $520.4M | $510.8M | ||
| Preferred stock, par value (in dollars per share) | $0 | $0 | ||
| Preferred stock, authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, shares authorized (in shares) | 75.0M shares | 75.0M shares | ||
| Common stock, shares issued (in shares) | 29.6M shares | 30.4M shares | ||
| Common stock, shares outstanding (in shares) | 29.6M shares | 30.4M shares | ||
| Common stock, par value (in dollars per share) | $0 | $0 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $18.3M | $20.0M | $15.2M |
| Depreciation and amortization | $43.5M | $41.2M | $41.1M |
| Stock-based compensation | $8.1M | $4.5M | $4.2M |
| Amortization of deferred commissions | $12.6M | $12.5M | $11.5M |
| Provision for credit losses | $1.0M | $2.6M | $1.0M |
| Deferred income taxes | $5.1M | -$1.1M | -$1.7M |
| Loss on equity method investments | $190.0K | $230.0K | $384.0K |
| Change in fair value of non-marketable equity investments | $0 | $0 | -$425.0K |
| Other | -$1.3M | -$1.6M | -$891.0K |
| Accounts and unbilled receivables | $4.0M | -$537.0K | -$3.2M |
| Prepaid royalties | $1.9M | $655.0K | -$1.1M |
| Other prepaid expenses and other current assets | -$2.9M | -$1.4M | -$1.2M |
| Other assets | -$19.3M | -$15.7M | -$14.5M |
| Accounts payable and accrued expenses | $1.4M | -$5.0M | $4.8M |
| Accrued royalties | $405.0K | $633.0K | -$887.0K |
| Deferred revenue | -$1.9M | -$330.0K | $3.4M |
| Net cash provided by operating activities | $63.3M | $57.7M | $64.0M |
| Cash paid for acquisitions, net of cash acquired | -$35.1M | -$1.3M | -$6.6M |
| Proceeds from maturities of marketable securities | $52.1M | $69.2M | $28.2M |
| Proceeds from sale of marketable securities | $9.8M | $0 | $0 |
| Purchases of marketable securities | -$43.5M | -$74.4M | -$50.3M |
| Proceeds from sale of fixed assets | $41.0K | $0 | $0 |
| Purchase of other investments | -$1.5M | $0 | $0 |
| Proceeds from sale of non-marketable equity investments | $0 | $765.0K | $47.0K |
| Payments associated with capitalized software development | -$28.5M | -$26.7M | -$25.8M |
| Purchases of property and equipment | -$3.7M | -$1.4M | -$2.2M |
| Net cash used in investing activities | -$50.4M | -$34.0M | -$56.6M |
| Taxes paid related to net settlement of equity awards | -$2.5M | -$1.1M | -$934.0K |
| Payment of debt issuance costs | $0 | $0 | -$118.0K |
| Repurchases of common stock | -$30.0M | $0 | -$8.9M |
| Payment of cash dividends | -$3.7M | -$3.4M | -$3.1M |
| Net cash used in financing activities | -$36.3M | -$4.5M | -$13.0M |
| Net (decrease) increase in cash and cash equivalents | -$23.3M | $19.1M | -$5.7M |
| Effect of exchange rate changes on cash and cash equivalents | -$7.0K | -$36.0K | -$23.0K |
| Interest paid | $101.0K | $101.0K | $132.0K |
| Income taxes paid | $8.7M | $2.6M | |
| Purchases of property and equipment, accrued but not paid | $475.0K | $399.0K | $91.0K |
| Capitalized software development, accrued but not paid | $712.0K | $1.1M | $961.0K |
| Common stock issued as consideration for business combinations | $4.0M | $0 | $0 |
| Non-cash additions to operating lease ROU assets | $252.0K | $0 | $0 |
No quarter-by-quarter statement was filed.
Leadership
Who has led HEALTHSTREAM INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerRobert A. Frist Jr. Feb 21, 2006 to now13
- ChairRobert A. Frist Jr. Dec 29, 2021 to now14
- PresidentJ. Edward Pearson May 17, 2018 to Apr 28, 202315
- PresidentFred Perner Feb 17, 2006 to Feb 17, 200616
- Chief financial officerScott Alexander Roberts Feb 26, 2019 to now17
- Chief financial officerGerard M. Hayden Jr. May 23, 2008 to Dec 27, 201818
- Chief financial officerArthur E. Newman Feb 14, 2006 to Feb 14, 200619
- Chief financial officerSusan Brownie Apr 3, 2006 to Aug 1, 200720
- Chief operating officerJ. Edward Pearson May 17, 2018 to Apr 28, 202315
Board members and other officers (26)
- Senior Vice PresidentJennifer Hayes Lopresto Feb 3, 2026 to now21
- Senior Vice PresidentScott Fenstermacher Jan 28, 2021 to now22
- Senior VP, hStream SolutionsMichael Scott McQuigg Jan 29, 2019 to now23
- SVP & GM, Clinical SolutionsTrisha L. Coady Dec 17, 2018 to now24
- SVP, BusDev and GenCounselMichael Manning Collier Aug 23, 2017 to now25
- Senior Vice PresidentMichael Sousa Feb 26, 2010 to Mar 28, 202526
- Chief Technology OfficerJeffrey Doster May 21, 2008 to Mar 19, 201827
- Senior Vice PresidentKevin P. O'Hara Feb 20, 2007 to now28
- SVP of Finance and HRSusan Brownie Feb 14, 2006 to Feb 14, 200629
- Executive Vice PresidentArthur E. Newman Apr 3, 2006 to Mar 19, 201530
- Senior Vice PresidentJ. Edward Pearson Jun 21, 2006 to Mar 19, 201831
- Board memberAmir Alex Jahangir Jun 13, 2023 to now32
- Board memberTerry Allison Rappuhn Jan 11, 2022 to now33
- Board memberC. Martin Harris Sep 10, 2010 to Mar 18, 202034
- Board memberTate Deborah Taylor Sep 10, 2010 to now35
- Board memberMichael D. Shmerling Jan 3, 2006 to May 25, 202336
- Board memberJames Daniell Jan 18, 2006 to Jan 5, 201037
- Board memberRobert A. Frist Jr. Feb 21, 2006 to May 4, 202113
- Board memberJeffrey L. McLaren Mar 17, 2006 to now38
- Board memberLinda Rebrovick May 25, 2006 to now39
- Board memberRon Hinds May 25, 2006 to Aug 16, 200640
- Board memberThompson Dent May 25, 2006 to now41
- Board memberWilliam Stead May 25, 2006 to now42
- Board memberFrank Gordon May 31, 2006 to now43
- Board memberGerard M. Hayden Jr. Aug 15, 2006 to May 24, 200744
- Board memberDale W. Polley Sep 12, 2006 to Mar 19, 201945
Named in SEC Form D filings
People the company listed in its private-offering notices.
Timeline
- Feb 21, 2006New chief executive Robert A. Frist Jr. becomes CEO13
Filings
522 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 401 insider forms, 14 large holders, 1 private raises, 32 other. The latest 20:
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 29, 20264 EDGAR
- Sep 23, 20268-K EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 21, 2026SCHEDULE 13D EDGAR
- Sep 15, 20264 EDGAR
- Sep 15, 20268-K EDGAR
The 522 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
22 open-market trades by officers, directors and large owners since October 2021: 2 buys and 20 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | FRIST ROBERT A JRCEO and Chairman | Sale | 144,068 | $29.50 | $4.3M | Form 4 |
| Jul 6, 2026 | REBROVICK LINDADirector | Sale | 6,000 | $29.00 | $174.0K | Form 4 |
| Jun 1, 2026 | REBROVICK LINDADirector | Sale | 2,000 | $25.00 | $50.0K | Form 4 |
| May 28, 2026 | REBROVICK LINDADirector | Sale | 2,000 | $25.00 | $50.0K | Form 4 |
| May 20, 2026 | O'Hara Kevin PExecutive Vice President | Sale | 3,000 | $24.08 | $72.2K | Form 4 |
| Dec 10, 2025 | Cunningham JeffChief Technology Officer | Sale | 2,100 | $24.09 | $50.6K | Form 4 |
| Dec 8, 2025 | O'Hara Kevin PExecutive Vice President | Sale | 2,000 | $24.26 | $48.5K | Form 4 |
| Nov 26, 2025 | Taylor Tate DeborahDirector | Sale | 1,580 | $25.46 | $40.2K | Form 4 |
| Aug 27, 2025 | O'Hara Kevin PExecutive Vice President | Sale | 2,000 | $27.97 | $55.9K | Form 4 |
| Feb 27, 2025 | Fenstermacher ScottSenior Vice President | Sale | 2,000 | $33.15 | $66.3K | Form 4 |
| Aug 29, 2024 | Taylor Tate DeborahDirector | Sale | 1,400 | $28.53 | $39.9K | Form 4 |
| Aug 26, 2024 | Fenstermacher ScottSenior Vice President | Sale | 1,000 | $28.99 | $29.0K | Form 4 |
| Aug 7, 2024 | O'Hara Kevin PExecutive Vice President | Sale | 3,000 | $28.03 | $84.1K | Form 4 |
| May 1, 2024 | Fenstermacher ScottSenior Vice President | Sale | 1,000 | $26.19 | $26.2K | Form 4 |
| Feb 26, 2024 | Sousa MichaelExecutive Vice President | Sale | 15,000 | $27.25 | $408.8K | Form 4 |
| Feb 22, 2024 | Fenstermacher ScottSenior Vice President | Sale | 1,000 | $26.59 | $26.6K | Form 4 |
| Feb 22, 2024 | Coady Trisha LExecutive Vice President | Sale | 7,000 | $26.34 | $184.4K | Form 4 |
| Apr 27, 2023 | PEARSON J EDWARDPresident and COO | Sale | 15,150 | $24.96 | $378.1K | Form 4 |
| Feb 24, 2023 | Taylor Tate DeborahDirector | Sale | 3,374 | $25.26 | $85.2K | Form 4 |
| Jul 29, 2022 | MCLAREN JEFFREY LDirector | Sale | 5,000 | $24.17 | $120.8K | Form 4 |
All 22 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- WJRJJ Ventures, LLCSCHEDULE 13D, 1 filing Sep 21, 202647
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G, 3 filings Feb 9, 2024 to Jul 14, 202648
- VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 10, 2022 to Mar 27, 202649
Money raised
Private offerings the company reported to the SEC on Form D.
- Dec 15, 2025Raised $4 million in a private offering of equity Form D: 1 investor so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 4,080,144 | $111.2M | 0.0% | +228,215 |
| Dimensional Fund Advisors LP | 1,557,981 | $42.5M | 0.0% | +101,938 |
| Copeland Capital Management, LLC | 1,248,384 | $34.0M | 0.7% | −28,355 |
| First Eagle Investment Management, LLC | 1,183,796 | $32.3M | 0.0% | +758,098 |
| Vanguard Capital Management LLC | 1,045,298 | $28.5M | 0.0% | −2,629 |
| State Street Corp | 1,004,170 | $27.4M | 0.0% | +8,613 |
| Vanguard Portfolio Management LLC | 880,543 | $24.0M | 0.0% | −41,303 |
| Two Sigma Investments, LP | 805,584 | $22.0M | 0.0% | −38,836 |
| Geode Capital Management, LLC | 779,219 | $21.2M | 0.0% | +64,472 |
| Goldman Sachs Group Inc | 665,917 | $18.1M | 0.0% | +391,459 |
| Jpmorgan Chase & Co | 635,565 | $17.2M | 0.0% | +181,827 |
| Arrowstreet Capital, Limited Partnership | 433,651 | $11.8M | 0.0% | +55,706 |
| Renaissance Technologies LLC | 423,000 | $11.5M | 0.0% | −54,848 |
| Morgan Stanley | 382,954 | $10.4M | 0.0% | +13,968 |
| Northern Trust Corp | 379,711 | $10.3M | 0.0% | +18,034 |
| Creative Planning | 285,852 | $7.8M | 0.0% | +67,666 |
| Lazard Asset Management LLC | 240,950 | $6.6M | 0.0% | +83,742 |
| Aqr Capital Management LLC | 240,232 | $6.5M | 0.0% | +181,390 |
| Charles Schwab Investment Management Inc | 237,710 | $6.5M | 0.0% | −27,934 |
| Bank of New York Mellon Corp | 227,493 | $6.2M | 0.0% | +3,856 |
| Kennedy Capital Management LLC | 191,504 | $5.2M | 0.1% | −3,737 |
| Nuveen, LLC | 189,904 | $5.2M | 0.0% | +138,153 |
| Envestnet Asset Management Inc | 189,539 | $5.2M | 0.0% | −10,092 |
| Fmr LLC | 166,812 | $4.5M | 0.0% | −8,338 |
| Sei Investments Co | 157,794 | $4.3M | 0.0% | +11,394 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARRobert A. Frist Jr., Chair
- 15SEC EDGARJ. Edward Pearson, President
- 16SEC EDGARFred Perner, President
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26SEC EDGARMichael Sousa, Senior Vice President
- 27
- 28
- 29SEC EDGARSusan Brownie, SVP of Finance and HR
- 30
- 31
- 32SEC EDGARAmir Alex Jahangir, Board member
- 33SEC EDGARTerry Allison Rappuhn, Board member
- 34SEC EDGARC. Martin Harris, Board member
- 35SEC EDGARTate Deborah Taylor, Board member
- 36SEC EDGARMichael D. Shmerling, Board member
- 37SEC EDGARJames Daniell, Board member
- 38SEC EDGARJeffrey L. McLaren, Board member
- 39SEC EDGARLinda Rebrovick, Board member
- 40SEC EDGARRon Hinds, Board member
- 41SEC EDGARThompson Dent, Board member
- 42SEC EDGARWilliam Stead, Board member
- 43SEC EDGARFrank Gordon, Board member
- 44SEC EDGARGerard M. Hayden Jr., Board member
- 45SEC EDGARDale W. Polley, Board member
- 46
- 47
- 48
- 49